Skip to content
POM-V Prescription Required

Poulvac IB QX Lyophilisate for Oculonasal Suspension for Chickens

Active ingredient: Infectious bronchitis virus

Form

Lyophilisate

Species

Chickens

Manufacturer

Zoetis UK Limited

VMD MA No.

42058/5103

What it's used for

Onset of immunity: 3 weeks after vaccination. Duration of immunity: 63 days after vaccination.

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Infectious bronchitis virus

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Poulvac IB QX Lyophilisate for Oculonasal Suspension for Chickens — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Onset of immunity: 3 weeks after vaccination.
Duration of immunity: 63 days after vaccination.
Future layers or breeders: one dose of vaccine from 7 days of age by spray
vaccination. The vaccine may be administered as early as 1 day of age to future
layers or breeders with MDAs against IBV.
Administration
The veterinary medicinal product can be used in most types of spray equipment. The
equipment should provide coarse spray (droplets greater than 100 μm). The distance
from the spraying head to the bird is dependent upon the type of sprayer used. It is
recommended to consult the instructions from the manufacturer of the spraying
device before use. Resuspension volumes vary based upon the type of spray
equipment as well. The recommended resuspension volume for 1 dose is between
0.15 and 0.5 ml.
Remove the aluminium seal from the vaccine vial. To dissolve the vaccine pellet, the
rubber stopper should be removed whilst the vial is immersed in a plastic measuring
jug containing 1 litre of clean cool water. Half fill the vial with water, replace the
stopper and shake to dissolve any remaining vaccine. The vaccine concentrate
should then be added to the water in the spray tank and thoroughly mixed.
Administer at a rate of one dose of prepared vaccine per bird.
Upon reconstitution, transparent to white opaque suspension (depending on the
volume of diluent used).
None.
AN: 03378/2025Page 2 of 6
Chickens:
Very rare
(< 1 animal / 10,000 animals
treated, including isolated
reports)
respiratory signs
1
Generally mild and last a few days.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See also section 16 of the
package leaflet for respective contact details.
The vaccine virus is capable of spreading to in contact birds for a minimum of 14
days after vaccination and appropriate care should be taken to separate vaccinated
from non-vaccinated chickens. Precautionary measures should be taken to prevent
spreading to wildlife.
Cleaning and disinfection of the premises after vaccination is advisable.
This vaccine should only be used after it has been established that the QX-like IBV
variant strain is epidemiologically relevant.
It is important to avoid introduction of the IB QX vaccine virus into premises in which
the wild type strain is not present. The IB QX vaccine should only be applied in
hatcheries if adequate controls are in place to avoid the spread of the vaccine virus
to birds that will be transported to non-IB QX exposed flocks.
The vaccine has been demonstrated to provide protection against QX-like variant.
The protection against other circulating IB strains has not been investigated.
As there is a small range between the efficacious vaccine dose and a non-efficacious
dose, take care to administer the right dose.
Vaccinate healthy animals only.

Special precautions for safe use in the target species:
All chickens on the site should be vaccinated at the same time.
When vaccination is planned in future layers or breeders younger than 7 days, the
parent flock should be vaccinated with an IB vaccine to ensure progeny with MDAs
against IBV.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Care should be taken when reconstituting and administering the vaccine. Wear a
suitable respiratory mask and eye protection to avoid direct contact with the
aerosolized vaccine. Wash and disinfect hands after use.
Special precautions for the protection of the environment:
Not applicable.
AN: 03378/2025Page 3 of 6
Safety and efficacy data are available which demonstrate that this vaccine can be
administered by coarse spray after administration of Poulvac IB Primer (where
authorised) from day of age onwards by coarse spray and eyedrop with a 7 to 14 day
interval between both administrations. For the associated use, the onset of immunity
is 21 days after the Poulvac IB QX vaccination for the claimed protection against QX-
like IBV strain and the onset of immunity is 27 days against Massachusetts serotype
and D274-like strains of IBV after the Poulvac IB Primer vaccination. An onset of
immunity of 21 days after the second vaccination against IBV Variant 2 (IS-1494-like)
and 793B serotype strains has also been established for the associated use, with
Poulvac IB Primer as detailed above, as demonstrated by a reduction of respiratory
signs caused by Variant 2 (IS-1494-like) and 793B serotype strains of IBV (as
assessed by the ciliary activity of tracheal explants). The possible interference of
MDAs on efficacy against Variant 2 and 793B serotype strains was not investigated.
The safety parameters and adverse events are not different from those described for
the vaccines administered separately.
No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product except the product mentioned above. A
decision to use this vaccine before or after any other veterinary medicinal product
therefore needs to be made on a case by case basis.
AN: 03378/2025Page 4 of 6
Store and transport refrigerated (2 C – 8 C).
Do not freeze.
Protect from light.
Zero days.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.